Pharmacokinetics and Biochemical Efficacy of an α1-Proteinase Inhibitor (Aralast NP) in α1-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis-Reference-Cited by-同舟云学术

Pharmacokinetics and Biochemical Efficacy of an α1-Proteinase Inhibitor (Aralast NP) in α1-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis

Published:2022-08-24 Issue:3 Volume:8 Page:311-326
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Li Zhaoyang^ORCID,Franke Ryan M.,Morris Denise N.,Yel Leman

Funder

Takeda Development Center Americas Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

https://link.springer.com/content/pdf/10.1007/s41030-022-00199-4.pdf

Reference18 articles.

1. Cazzola M, Stolz D, Rogliani P, Matera MG. α1-antitrypsin deficiency and chronic respiratory disorders. Eur Respir Rev. 2020;29(155): 190073. https://doi.org/10.1183/16000617.0073-2019.

2. Greene CM, Marciniak SJ, Teckman J, Ferrarotti I, Brantly ML, Lomas DA, et al. α1-antitrypsin deficiency. Nat Rev Dis Primers. 2016;2:16051. https://doi.org/10.1038/nrdp.2016.51.

3. Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–55. https://doi.org/10.1056/NEJMra1910234.

4. Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, et al; RAPID Trial Study Group. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(9991):360–8. https://doi.org/10.1016/S0140-6736(15)60860-1.

5. McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, et al; RAPID Extension Trial Group. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). Lancet Respir Med. 2017;5(1):51–60. https://doi.org/10.1016/s2213-2600(16)30430-1.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin deficiency;Pulmonary Pharmacology & Therapeutics;2023-12